CompletedPhase 2NCT00036569

A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine Gliomas

Studying Diffuse intrinsic pontine glioma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Cancer Institute (NCI)
Principal Investigator
Kathy Warren, M.D., MD, PhD
National Cancer Institute (NCI)
Intervention
adjuvant therapy(procedure)
Enrollment
32 enrolled
Eligibility
21 years · All sexes
Timeline
2002 – 2012

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00036569 on ClinicalTrials.gov

Other trials for Diffuse intrinsic pontine glioma

Additional recruiting or active studies for the same condition.

See all trials for Diffuse intrinsic pontine glioma →

← Back to all trials